In what circumstances could nondaily preexposure prophylaxis for HIV substantially reduce program costs?-Reference-Cited by-同舟云学术

In what circumstances could nondaily preexposure prophylaxis for HIV substantially reduce program costs?

Published:2018-03-27 Issue:6 Volume:32 Page:809-818
ISSN:0269-9370
Container-title:AIDS
language:en
Short-container-title:

Author:

Mitchell Kate M.,Dimitrov Dobromir,Hughes James P.,Xia Fan,Donnell Deborah,Amico K. Rivet,Bokoch Kevin,Chitwarakorn Anupong,Bekker Linda-Gail,Holtz Timothy H.,Mannheimer Sharon,Grant Robert M.,Boily Marie-Claude

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Infectious Diseases,Immunology,Immunology and Allergy

Reference38 articles.

1. HIV pre-exposure prophylaxis (PrEP): a review of current knowledge of oral systemic HIV PrEP in humans;Spinner;Infection,2016

2. The cost and impact of scaling up pre-exposure prophylaxis for HIV prevention: a systematic review of cost-effectiveness modelling studies;Gomez;PLoS Med,2013

3. What do we know about the cost–effectiveness of HIV preexposure prophylaxis, and is it affordable?;Cambiano;Curr Opin HIV AIDS,2016

4. On-demand preexposure prophylaxis in men at high risk for HIV-1 infection;Molina;N Engl J Med,2015

5. Safety and adherence to intermittent pre-exposure prophylaxis (PrEP) for HIV-1 in African men who have sex with men and female sex workers;Mutua;PLoS One,2012

Cited by 15 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Interest in event-driven PrEP among men who have sex with men using daily PrEP in Mexico in 2019–2020: a cross-sectional assessment in a large-scale demonstration project;AIDS Care;2024-08-08

2. Correlates of oral pre-exposure prophylaxis cessation among men who have sex with men in China: implications from a nationally quantitative and qualitative study;BMC Public Health;2024-07-02

3. Willingness to use and intention to adhere to pre-exposure prophylaxis (PrEP) among men who have sex with men in Jiangsu Province, China;AIDS Care;2023-04-19

4. Health Economics Research on Non-surgical Biomedical HIV Prevention: Identifying Gaps and Proposing a Way Forward;PharmacoEconomics;2023-03-11

5. Costs and Cost-Effectiveness of Biomedical, Non-Surgical HIV Prevention Interventions: A Systematic Literature Review;PharmacoEconomics;2022-12-19